Abbott Laboratories (ABT) Buildings (2009 - 2025)

Abbott Laboratories (ABT) has 17 years of Buildings data on file, last reported at $4.5 billion in Q4 2025.

• For the quarter ending Q4 2025, Buildings rose 7.99% year-over-year to $4.5 billion; the trailing twelve-month figure through Dec 2025 stood at $4.5 billion (up 7.99% YoY), and the FY2025 full-year result was $4.5 billion, up 7.99% from the prior year.
• Buildings rose to $4.5 billion in Q4 2025, from $4.2 billion in the prior quarter.
• In the past five years, Buildings ranged from a high of $4.5 billion in Q4 2025 to a low of $4.0 billion in Q4 2021.
• A 5-year average of $4.2 billion and a median of $4.2 billion in 2023 frame the typical range for Buildings.
• Across the five-year window, Buildings slipped 0.17% in 2021 and rose 7.99% in 2025, its largest moves.
• Tracing ABT's Buildings over 5 years: stood at $4.0 billion in 2021, then grew by 1.15% to $4.1 billion in 2022, then grew by 2.66% to $4.2 billion in 2023, then advanced by 1.11% to $4.2 billion in 2024, then grew by 7.99% to $4.5 billion in 2025.
• Business Quant data shows ABT's Buildings at $4.5 billion in Q4 2025, $4.2 billion in Q4 2024, and $4.2 billion in Q4 2023.